BiTE® Immuno-Oncology Platform
Learn about the mechanism of action and the potential promise of the BiTE® immuno-oncology platform.
BiTE® Technology
Discover the BiTE® Interactive Experience
An immersive and dynamic experience that explores multiple cancer environments and how BiTE® technology can be used with the goal of targeting different tumor types.
DLL3 Target for the BiTE® Platform (Educational Booklet)
Learn more about the DLL3 protein, which is expressed on the surface of many tumor cells.
BiTE: The Engager™
The latest educational resource on the BiTE® immuno-oncology platform.
PSMA in mCRPC DSE Slide Deck
PSMA—a clinically validated target in metastatic castration-resistant prostate cancer (mCRPC).
The BiTE® Immuno-Oncology Platform Fact Sheet
A quick and easily accessible reference for the BiTE® immuno-oncology platform.
Pipeline & Clinical Trials
CodeBreaK HCP Website
A clinical trial program for patients with non-small cell lung cancer (NSCLC) whose cancer has the KRAS G12C mutation.
Amgen’s Oncology Pipeline Chart
A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with meaningful effects in serious diseases.
Amgen’s Oncology Pipeline Interactive
A comprehensive interactive resource for Amgen’s oncology pipeline, including molecules, targets, malignancies, and clinical trials.
Clinical Trials Brochure
Learn more about key clinical trials happening in Amgen oncology.
